NEWS

NEWS 2022.7.5 Rebirthel won the JETRO award at the 7th HVC (Healthcare Venture Conference) KYOTO 2022.

HVC Kyoto, Japan’s largest English-spoken pitch event specializing in health care, was held on ...

NEWS 2022.6.17 2022 BIO International Convention

Rebirthel participated in the exhibition “2022 BIO International Convention”, held at San Diego...

NEWS 2022.6.9 We will be exhibiting at the 2022 BIO International Convention

“2022 BIO International Convention (BIO2022)” will be held at San Diego Convention Center from ...

NEWS 2022.3.28 Rebirthel is nominated as a finalist in three categories for Informa Pharma Intelligence Awards

Informa Pharma Intelligence is the Japanese version of Scrips Awards which is world famous with...

NEWS 2022.3.3 Rebirthel won the Kyoto University Award at 3rd Kyoto University LifeScience Showcase 2022 @ San Diego

Graduate School of Medicine, Kyoto University has its research center on the campus of Universi...

NEWS , Press release 2021.12.16 Rebirthel and Otsuka Sign Licensing Agreement for iPSC-derived CAR-T / TCR-T Production Technology

Rebirthel Co., Ltd. announces that it entered into an exclusive commercial licensing agreement ...

Media , NEWS 2021.10.22 Rebirthel was featured on Nihon Keizai Shimbun (Japanese newspaper)

In the morning edition of Nihon Keizai Shimbun on October 22nd, 2021 (Page 18, Technology), Reb...

NEWS 2021.10.15 Japan Healthcare Venture Summit 2021

Rebirthel participated in the exhibition “Japan Healthcare Venture Summit 2021 (JHVS2021)”, hel...

NEWS , メディア 2021.8.18 Rebirthel was introduced on the web magazine “Nikkei Biotechnology & Business”

“The dictionary of Biotech Startups in Japan 2021-2022” which covers over 400 bio venture compa...